Integra LifeSciences Holdings Corporation (IART)

NASDAQ: IART · Real-Time Price · USD

15.22

+0.12 (0.79%)

At close: Sep 18, 2026, 4:00 PM EDT

15.22

0.00 (0.00%)

After-hours: Sep 18, 2026, 5:04 PM EDT

IART Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,648	1,635	1,611	1,542	1,558	1,542
Revenue Growth	1.60%	1.54%	4.47%	-1.03%	0.99%	12.43%
Gross Profit	937.07	919.42	959.12	884.74	970.31	944.64
Operating Income	163.4	145.92	181.98	111.53	238.92	199.98
Net Income	-7.24	-516.47	-6.94	67.74	180.55	169.08
Earnings Per Share	-0.10	-6.74	-0.09	0.84	2.16	1.98
EPS Growth	-	-	-	-61.11%	9.09%	26.11%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Tissue Reconstruction	439.37	434.73	466.89	482.58	538.1	517.22
Specialty Surgery	1,208	1,201	1,144	1,059	1,020	1,025
Total	1,648	1,635	1,611	1,542	1,558	1,542

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	274.08	263.74	273.57	309.1	456.66	513.45
Total Debt	2,050	2,035	1,986	1,684	1,615	1,700
Net Cash (Debt)	-1,776	-1,771	-1,713	-1,374	-1,159	-1,186
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-23.08	-23.10	-22.24	-17.11	-13.87	-13.88

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	85.33	50.38	129.38	139.96	264.47	312.43
Capital Expenditures	-59.53	-81.44	-104.42	-66.87	-42.34	-48.02
Free Cash Flow	25.8	-31.05	24.96	73.09	222.13	264.41
Free Cash Flow Growth	-	-	-65.84%	-67.09%	-15.99%	60.30%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	56.87%	56.23%	59.55%	57.39%	62.29%	61.24%
Operating Margin	9.92%	8.92%	11.30%	7.23%	15.34%	12.96%
Pretax Margin	-0.01%	-34.46%	-1.13%	5.26%	13.73%	13.92%
Profit Margin	-0.44%	-31.58%	-0.43%	4.39%	11.59%	10.96%
FCF Margin	1.57%	-1.90%	1.55%	4.74%	14.26%	17.14%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	50.26	25.94	33.56
Forward PE	5.99	5.21	8.83	12.94	16.16	20.19
P/FCF Ratio	45.03	-	70.10	46.58	21.08	21.46
PS Ratio	0.71	0.59	1.09	2.21	3.01	3.68